Product Deployment, Recognitions, Stock Price Updates, Financial Results, and Positive Court Rulings - Analyst Notes on

Product Deployment, Recognitions, Stock Price Updates, Financial Results, and
  Positive Court Rulings - Analyst Notes on Microchip, Teradyne, Ambarella,
                            Spansion, and ReneSola

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

NEW YORK, March 19, 2014

NEW YORK, March 19, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Microchip
Technology Inc. (NASDAQ: MCHP), Teradyne, Inc. (NYSE: TER), Ambarella Inc
(NASDAQ: AMBA), Spansion Inc. (NYSE: CODE), and ReneSola Ltd. (NYSE: SOL).
Private wealth members receive these notes ahead of publication. To reserve
complementary membership, limited openings are available at:



On March 4, 2014, Microchip Technology Inc. (Microchip) reported that it has
been recognized by 11 global electronic industry publications for the product
innovation and technology leadership of its patented GestIC® technology.
Microchip stated that the GestIC® technology allows the next dimension in
intuitive, gesture-based, non-contact user interfaces for a broad range of end
products. The Company informed that MGC3130, the world's first
electrical-field (E-field)-based 3D gesture controller that utilizes GestIC
technology to provide low-power, precise, fast and robust hand position
tracking with free-space gesture recognition, has won five awards in the
Americas, three in Asia, and three in Europe. "The sheer number of awards that
we've won is a testament to our GestIC technology's ability to enable new and
innovative user-interface capabilities in a broad range of products," said
Fanie Duvenhage, Director of Microchip's Human Machine Interface Division.
"Our MGC3130 controller represents a gigantic leap forward in 3D, touchless
gesture-interface technology, in terms of cost, performance and power
consumption." The full analyst notes on Microchip Technology Inc. are
available to download free of charge at:



On March 14, 2014, shares of Teradyne, Inc. (Teradyne) gained 0.16% to end the
day's trading at $19.28. Shares of Teradyne declined 1.68% over the past three
trading sessions, as compared to the S&P 500 Index which dropped 1.42% during
the same period. The full analyst notes on Teradyne, Inc. are available to
download free of charge at:



On March 6, 2014, Ambarella Inc. (Ambarella) released its Q4 FY 2014 and FY
2014 financial results (period ended January 31, 2014). Total revenues for Q4
FY 2014 increased 26.8% YoY to $40.0 million, and total revenues in FY 2014
increased 30.2% YoY to $157.6 million. Ambarella's Q4 FY 2014 net income was
$5.5 million or $0.18 per diluted share, versus $3.6 million or $0.13 per
diluted share in Q4 FY 2013. Net income stood at $25.7 million or $0.85 per
diluted share in FY 2014, versus $18.2 million or $0.60 per diluted share in
FY 2013. Commenting on the results, Fermi Wang, President and CEO of Fermi
Wang, stated, "We are very pleased with our fourth quarter and fiscal year
2014 financial results. During the fourth quarter we had revenue of $40M, up
26.8% from the same period last year. Our revenue for the whole fiscal year
was up 30.2% from last year, while revenue from IP-security cameras more than
doubled. In Q4 we introduced innovative surround-view solutions for the
automotive market and collaborated with Google to explore new opportunities in
wearable cameras. We look forward to driving continued innovation in the year
ahead." The full analyst notes on Ambarella Inc. are available to download
free of charge at:



On March 11, 2014, Spansion Inc. (Spansion) reported that the United States
District Court of Virginia has ruled two decisions in the Company's favor. The
Company informed that the first court order dismissed the case filed by
Macronix against Spansion, stating that Macronix's allegations have failed to
state a valid case for patent infringement. The Company added that in the
second order, the court held that, if Macronix files another complaint, the
case will be transferred to the U.S. District Court of the Northern District
of California, which could take more than a year for a decision. Ali
Poukeramati, Senior Vice President of Spansion, said, "We are pleased with the
Court's decision, which confirms that Macronix's complaint failed to
demonstrate infringement, and should provide relief to our customers. Since
this is the second time that the court in Virginia has dismissed Macronix's
complaint against Spansion for this exact same reason, it is obvious that
Macronix filed this case only to deflect attention from the suit filed by
Spansion against Macronix with the International Trade Commission (ITC)." The
full analyst notes on Spansion Inc. are available to download free of charge



On March 13, 2014, ReneSola Ltd. (ReneSola) announced that it will deliver 66
Replus string inverters and 100 Micro Replus micro inverters to Enlightened
Solar. According to ReneSola, the inverters, along with 2,000 ReneSola 240W
and 260W Virtus II modules will be installed by Enlightened Solar on a series
of new housing projects in the United Kingdom. Commenting on the update, Geoff
Fox, Managing Director of Enlightened Solar said, "We chose ReneSola products
because of the long expertise that the company has in supplying top quality
equipment. The ease of procurement and full after sales service from the UK
office made ReneSola an easy choice." The full analyst notes on ReneSola Ltd.
are available to download free of charge at:


We provide our members with a simple and reliable way to leverage our economy
of scale. Most investors do not have time to track all publicly traded
companies, much less perform an in-depth review and analysis of the
complexities contained in each situation. That's where Analysts Review comes
in. We provide a single unified platform for investors' to hear about what
matters. Situation alerts, moving events, and upcoming opportunities.




  oThis is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
  oInformation in this release is fact checked and produced on a best efforts
    basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
  oThis information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
  oIf you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at pubco [at]
  oForanyurgentconcernsorinquiries, please contact us at compliance
  oAre you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to research [at] for consideration.


Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Analysts Review. An
outsourced research services provider represented by Nidhi Vatsal, CFA, has
only reviewed the information provided by Analysts Review in this article or
report according to the Procedures outlined by Analysts Review. Analysts
Review is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.


Analysts Review makes no warranty, expressed or implied, as to the accuracy or
completeness or fitness for a purpose (investment or otherwise), of the
information provided in this document. This information is not to be construed
as personal financial advice. Readers are encouraged to consult their personal
financial advisor before making any decisions to buy, sell or hold any
securities mentioned herein.


Analysts Review is not responsible for any error which may be occasioned at
the time of printing of this document or any error, mistake or shortcoming. No
liability is accepted by Analysts Review whatsoever for any direct, indirect
or consequential loss arising from the use of this document. Analysts Review
expressly disclaims any fiduciary responsibility or liability for any
consequences, financial or otherwise arising from any reliance placed on the
information in this document. Analysts Review does not (1) guarantee the
accuracy, timeliness, completeness or correct sequencing of the information,
or (2) warrant any results from use of the information. The included
information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA

SOURCE Analysts Review

Contact: Adam Redford CONTACT PHONE: +852-8191-3972
Press spacebar to pause and continue. Press esc to stop.